These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 11748176)

  • 1. CpG oligodeoxynucleotides enhance host defense during murine tuberculosis.
    Juffermans NP; Leemans JC; Florquin S; Verbon A; Kolk AH; Speelman P; van Deventer SJ; van der Poll T
    Infect Immun; 2002 Jan; 70(1):147-52. PubMed ID: 11748176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased levels of interferon-gamma primed by culture filtrate proteins antigen and CpG-ODN immunization do not confer significant protection against Mycobacterium tuberculosis infection.
    Fonseca DM; Silva CL; Paula MO; Soares EG; Marchal G; Horn C; Bonato VL
    Immunology; 2007 Aug; 121(4):508-17. PubMed ID: 17433075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IFN-γ-mediated efficacy of allergen-free immunotherapy using mycobacterial antigens and CpG-ODN.
    Fonseca DM; Paula MO; Wowk PF; Campos LW; Gembre AF; Turato WM; Ramos SG; Dias-Baruffi M; Barboza R; Gomes E; Horn C; Marchal G; Arruda LK; Russo M; Bonato VL
    Immunol Cell Biol; 2011 Oct; 89(7):777-85. PubMed ID: 21403663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary mucosal immunity mediated through CpG provides adequate protection against pulmonary Mycobacterium tuberculosis infection in the mouse model. A role for type I interferon.
    Troy A; Esparza-Gonzalez SC; Bartek A; Creissen E; Izzo L; Izzo AA
    Tuberculosis (Edinb); 2020 Jul; 123():101949. PubMed ID: 32741537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CpG oligodeoxynucleotides and interleukin-12 improve the efficacy of Mycobacterium bovis BCG vaccination in mice challenged with M. tuberculosis.
    Freidag BL; Melton GB; Collins F; Klinman DM; Cheever A; Stobie L; Suen W; Seder RA
    Infect Immun; 2000 May; 68(5):2948-53. PubMed ID: 10768993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oligodeoxynucleotides containing CpG motifs modulate the allergic TH2 response of BALB/c mice to Bet v 1, the major birch pollen allergen.
    Jahn-Schmid B; Wiedermann U; Bohle B; Repa A; Kraft D; Ebner C
    J Allergy Clin Immunol; 1999 Nov; 104(5):1015-23. PubMed ID: 10550747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of a hexameric deoxyriboguanosine run conjugation into CpG oligodeoxynucleotides on their immunostimulatory potentials.
    Lee SW; Song MK; Baek KH; Park Y; Kim JK; Lee CH; Cheong HK; Cheong C; Sung YC
    J Immunol; 2000 Oct; 165(7):3631-9. PubMed ID: 11034366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CpG oligodeoxynucleotides do not require TH1 cytokines to prevent eosinophilic airway inflammation in a murine model of asthma.
    Kline JN; Krieg AM; Waldschmidt TJ; Ballas ZK; Jain V; Businga TR
    J Allergy Clin Immunol; 1999 Dec; 104(6):1258-64. PubMed ID: 10589010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A study on the mechanisms of mycobacterial clearance induced by CpG-oligodeoxynucleotides in mice].
    Ren T; Liang YJ; Cai YY; Li CY; Mei J; Yuan ZH; Tao MF; Tian M; Zhao B
    Zhonghua Jie He He Hu Xi Za Zhi; 2008 Jan; 31(1):46-50. PubMed ID: 18366907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three CpG oligodeoxynucleotide classes differentially enhance antigen-specific humoral and cellular immune responses in mice.
    Liu Y; Luo X; Yang C; Yu S; Xu H
    Vaccine; 2011 Aug; 29(34):5778-84. PubMed ID: 21664398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunomodulatory effects of CpG oligodeoxynucleotides on established th2 responses.
    Kitagaki K; Jain VV; Businga TR; Hussain I; Kline JN
    Clin Diagn Lab Immunol; 2002 Nov; 9(6):1260-9. PubMed ID: 12414759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity.
    Chu RS; Targoni OS; Krieg AM; Lehmann PV; Harding CV
    J Exp Med; 1997 Nov; 186(10):1623-31. PubMed ID: 9362523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CpG motifs of bacterial DNA exacerbate colitis of dextran sulfate sodium-treated mice.
    Obermeier F; Dunger N; Deml L; Herfarth H; Schölmerich J; Falk W
    Eur J Immunol; 2002 Jul; 32(7):2084-92. PubMed ID: 12115630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Newly identified CpG ODNs, M5-30 and M6-395, stimulate mouse immune cells to secrete TNF-alpha and enhance Th1-mediated immunity.
    Choi SS; Chung E; Jung YJ
    J Microbiol; 2010 Aug; 48(4):512-7. PubMed ID: 20799094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapeutic effects and mechanisms of CpG oligodeoxynucleotides in mice infected with Mycobacterium tuberculosis].
    Ren T; Li CY; Cai YY; Jin ML; Hu YW; Yuan ZH; Tian M; Zhao B
    Zhonghua Jie He He Hu Xi Za Zhi; 2006 Feb; 29(2):87-91. PubMed ID: 16677448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CpG-containing oligodeoxynucleotides, in combination with conventional adjuvants, enhance the magnitude and change the bias of the immune responses to a herpesvirus glycoprotein.
    Ioannou XP; Gomis SM; Karvonen B; Hecker R; Babiuk LA; van Drunen Littel-van den Hurk S
    Vaccine; 2002 Nov; 21(1-2):127-37. PubMed ID: 12443671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oligodeoxynucleotides without CpG motifs work as adjuvant for the induction of Th2 differentiation in a sequence-independent manner.
    Sano K; Shirota H; Terui T; Hattori T; Tamura G
    J Immunol; 2003 Mar; 170(5):2367-73. PubMed ID: 12594259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Requirements for effective inhibition of immunostimulatory CpG motifs by neutralizing motifs.
    Zhao H; Cheng SH; Yew NS
    Antisense Nucleic Acid Drug Dev; 2000 Oct; 10(5):381-9. PubMed ID: 11079577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CpG DNA induces sustained IL-12 expression in vivo and resistance to Listeria monocytogenes challenge.
    Krieg AM; Love-Homan L; Yi AK; Harty JT
    J Immunol; 1998 Sep; 161(5):2428-34. PubMed ID: 9725240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carbonate Apatite Nanoparticles Act as Potent Vaccine Adjuvant Delivery Vehicles by Enhancing Cytokine Production Induced by Encapsulated Cytosine-Phosphate-Guanine Oligodeoxynucleotides.
    Takahashi H; Misato K; Aoshi T; Yamamoto Y; Kubota Y; Wu X; Kuroda E; Ishii KJ; Yamamoto H; Yoshioka Y
    Front Immunol; 2018; 9():783. PubMed ID: 29720976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.